TY  - JOUR

T1  - Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

JO  - The Lancet

UR  - http://eprints.whiterose.ac.uk/169309/

PY  - 2020/12/08

AU  - Voysey M

AU  - Clemens SAC

AU  - Madhi SA

AU  - Weckx LY

AU  - Folegatti PM

AU  - Aley PK

AU  - Angus B

AU  - Baillie VL

AU  - Barnabas SL

AU  - Bhorat QE

AU  - Bibi S et al

ED  - 

DO  - DOI: 10.1016/s0140-6736(20)32661-1

PB  - Elsevier BV

VL  - 397

IS  - 10269

SP  - 99

EP  - 111

Y2  - 2024/09/19

ER  -